Light Mode
$0.0231 ↓ -0.0009 (-3.75%) Trading Down from the previous close of $0.0240, and at the day’s high of $0.0242
+0.01 (+34.30%) / 6M
Momentum, market sentiment, and recent alerts
CYVNY reads n/a: the 12-month move is +34.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Ceryvyn Therapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and research of novel therapeutic products based on targeting Vascular Endothelial Growth Factors. It operates through the United States and Australia geographical segments. The company was founded by Dr. Megan Baldwin on October 17, 1984, and is headquartered in Melbourne, Australia.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.